✦ LIBER ✦

Adefovir dipivoxil (ADV) for the treatment of patients with chronic hepatitis B (CHB) failing lamivudine (LAM) therapy

✍ Scribed by F. Zoulim; C. Trepo; T. Poynard; S. Pol; J.P. Zarski; P. Marcellin; M. Beaugrand; V. Stitruk; A. Trylesinski; K. Kleber; S. Van Doren; C. Brosgart

Book ID: 117372106
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 153 KB
Volume: 38
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)80012-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

545 Adefovir dipivoxil (ADV) is effectiv

545 Adefovir dipivoxil (ADV) is effective for the treatment of patients with LAM-R chronic hepatitis B (CHB) in cirrhotic and elderly patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Resistance surveillance of HBEAG— chroni

Resistance surveillance of HBEAG— chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV)

✍ S. Xiong; H. Yang; C.E. Westland; W.E. Delaney IV; D. Colledge; A. Bartholomeusz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Changes in alanine aminotransferase (ALT

Changes in alanine aminotransferase (ALT) and YMDD mutation profile associated with switching from lamivudine (LAM) to either adefovir dipivoxil (ADV) or combination LAM plus ADV in chronic hepatitis B (CHB) patients with LAM resistance

✍ Peters, Marion; Martin, Paul; Sullivan, Mark; Kleber, Kristin; Ebrahimi, Ramin; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 247 KB

438 Continued safety and efficacy of add

438 Continued safety and efficacy of adding adefovir dipivoxil (ADV) to ongoing lamivudine (LAM) therapy in compensated chronic hepatitis B (CHB) patients with YMDD variant HBV: 2 year results

✍ R. Perrillo; B. Willems; N. Leung; C. Trepo; H.W.L. Hann; G. Lau; W.M. Lee; E. S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

521 Long-term antiviral therapy with lam

521 Long-term antiviral therapy with lamivudine (LAM) and salvage adefovir dipivoxil (ADV) improves the outcome of patients with HBeAg-negative chronic hepatitis B (CHBe-)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Lamivudine compared with lamivudine and

Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B

✍ Joseph J.Y. Sung; Jak-Yiu Lai; Stefan Zeuzem; Wan Chen Chow; E. Jenny Heathcote; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 146 KB